Medical Education Grant Requests

What types of grants do we fund?

Educational Grants

Professional and educational grants will be considered with a preference for accredited continuing education (CE) programs. The primary audience for these grants should be healthcare professionals or patients. Ipsen may fund educational seminars, webinars and symposia; the development of educational materials; and other types of valuable educational programs. Award programs, scholarships and fellowships administered by non-profit entities or multiple healthcare institutions that further research in a therapeutic area of focus for Ipsen will also be considered.

Therapeutic Areas of Focus

Additionally, Ipsen will consider requests for funding education relating to epidemiology, diagnosis, and/or treatment in the following areas:

Rare Disease

  • Pituitary disease, including acromegaly
  • Hormonal dysfunction, including severe primary IGF-1 deficiency (SPIGFD)
  • Fibrodysplasia ossificans progressiva (FOP)

Neuroscience

  • Cervical dystonia and other dystonic disorders
  • Spasticity
  • Other movement disorders

Oncology

  • Gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
  • Carcinoid syndrome
  • Pancreatic cancer

Grant approvals are not connected to or conditioned upon the purchasing, prescribing, providing favorable recommendations for, or otherwise supporting Ipsen products. The funding of a grant request does not impose an obligation, expressed or implied, on the recipient to purchase, prescribe, provide favorable formulary status for, or otherwise support Ipsen products. Formal notifications of grant awards will be made in writing to the applicant organization and supersede any prior oral or written understandings or communications between the applicant and Ipsen.

Contact Us

For more information, contact us at ipsengrants@ipsen.com.

Types of Grants

What do you need to submit a grant?

To be considered for funding, the request should meet all of the criteria of an appropriate educational activity, including that it is independent, the information provided is balanced, accurate and not misleading, delivered to a broad audience and is reasonable in cost.

For consideration, grant applications must be submitted with all required documentation at least 90 days prior to the scheduled event. Grant requests will be reviewed by Ipsen’s Grant Review Committee on the basis of scientific, medical, and/or public health criteria.

Before consideration, a grant application must contain all of the following documents:

Letter of Request – including:

  • An educational need for the program
  • Learning objectives
  • Description of your organization and mission/purpose
  • What is being requested
  • Date and location of the activity
  • In the case of requests for a product grant (in-kind support), the requested quantity of drug and the way the drug will be used in the program

Agenda or brochure – including a detailed description of the event or a synopsis of materials to be created

Budget – a detailed budget for the total event/project, including

  • Total amount of funds requested from Ipsen
  • A breakdown of expenses and projected number of attendees
  • Percentage of funding requested from Ipsen to the total funding for the activity.  Preference will be given to those events funded by more than one donor
  • Percentage of Ipsen’s cumulative contribution vs. overall annual External Requestor’s budget.

W9 – tax form with tax ID number for the entity receiving payment. If an entity is tax exempt, you may submit a Letter of Exemption instead. Click here to download a W-9 form

CE Certificate – CE certificate for the provider. This requirement is waived for non-CE educational activities

Outcomes plan – explaining how the effect of the educational intervention will be measured

What You Need

Begin the Process

To request a grant, please submit your request to: ipsengrants@ipsen.com

Begin the Process

Click for information on Charitable Contributions

For information on Charitable Contributions, please click here
©2020 Ipsen Biopharmaceuticals, Inc. All rights reserved. June 2020 MP-US-000472